glp 1 military Pentagon Drops Coverage of GLP-1 Weight Loss Meds for Medicare-Eligible Retirees Weighing benefits: Could anti-obesity meds

In mouse studies, PTD-DBM promoted hair regrowth in alopecia models and demonstrated the ability to stimulate new follicle formation, something most treatments cannot do

28(5): 30711 Maehara M, Kinoshita S, Watanabe K

Executive Summary Quick Insight: The GLP-1 Weight Loss Drug Market is on track to more than double to USD 192 billion by 2035 , driven by explosive patient demand for injectable and oral incretin therapies, multi-indication label expansion beyond obesity into cardiovascular protection and metabolic disease management, a robust late-stage pipeline of next-generation triple agonists, and unprecedented payer engagement transforming obesity into a fully reimbursable chronic disease requiring long-term pharmacological management

Hydroxocobalamin should be given to a pregnant woman only if clearly needed